187 related articles for article (PubMed ID: 20350350)
21. Intravenous delivery of a chemically modified sulfamidase efficiently reduces heparan sulfate storage and brain pathology in mucopolysaccharidosis IIIA mice.
Gustavsson S; Ohlin Sjöström E; Tjernberg A; Janson J; Westermark U; Andersson T; Makower Å; Arnelöf E; Andersson G; Svartengren J; Ekholm C; Svensson Gelius S
Mol Genet Metab Rep; 2019 Dec; 21():100510. PubMed ID: 31528541
[TBL] [Abstract][Full Text] [Related]
22. Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery.
Fu H; DiRosario J; Kang L; Muenzer J; McCarty DM
J Gene Med; 2010 Jul; 12(7):624-33. PubMed ID: 20603889
[TBL] [Abstract][Full Text] [Related]
23. Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.
King B; Savas P; Fuller M; Hopwood J; Hemsley K
Mol Genet Metab; 2006 Feb; 87(2):107-12. PubMed ID: 16352454
[TBL] [Abstract][Full Text] [Related]
24. Genetic manipulation of murine embryonic stem cells with enhanced green fluorescence protein and sulfatase-modifying factor I genes.
Zhao G; Karageorgos L; Hutchinson RG; Hopwood JJ; Hemsley K
Cytotherapy; 2010 May; 12(3):400-7. PubMed ID: 20370351
[TBL] [Abstract][Full Text] [Related]
25. Hepatic differentiation of mouse embryonic stem cells in a three-dimensional culture system using polyurethane foam.
Matsumoto K; Mizumoto H; Nakazawa K; Ijima H; Funatsu K; Kajiwara T
J Biosci Bioeng; 2008 Apr; 105(4):350-4. PubMed ID: 18499050
[TBL] [Abstract][Full Text] [Related]
26. Generation and potential biomedical applications of embryonic stem cell-derived glial precursors.
Glaser T; Schmandt T; Brüstle O
J Neurol Sci; 2008 Feb; 265(1-2):47-58. PubMed ID: 17963783
[TBL] [Abstract][Full Text] [Related]
27. Immune or inflammatory response by the host brain suppresses neuronal differentiation of transplanted ES cell-derived neural precursor cells.
Ideguchi M; Shinoyama M; Gomi M; Hayashi H; Hashimoto N; Takahashi J
J Neurosci Res; 2008 Jul; 86(9):1936-43. PubMed ID: 18335525
[TBL] [Abstract][Full Text] [Related]
28. Further characterization of embryonic stem cell-derived radial glial cells.
Liour SS; Kraemer SA; Dinkins MB; Su CY; Yanagisawa M; Yu RK
Glia; 2006 Jan; 53(1):43-56. PubMed ID: 16158417
[TBL] [Abstract][Full Text] [Related]
29. Correction of mucopolysaccharidosis type IIIA somatic and central nervous system pathology by lentiviral-mediated gene transfer.
McIntyre C; Byers S; Anson DS
J Gene Med; 2010 Sep; 12(9):717-28. PubMed ID: 20683858
[TBL] [Abstract][Full Text] [Related]
30. In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocol.
Ozolek JA; Jane EP; Esplen JE; Petrosko P; Wehn AK; Erb TM; Mucko SE; Cote LC; Sammak PJ
Methods Mol Biol; 2010; 584():71-95. PubMed ID: 19907972
[TBL] [Abstract][Full Text] [Related]
31. Engineering embryonic stem cell derived glia for adenosine delivery.
Fedele DE; Koch P; Scheurer L; Simpson EM; Möhler H; Brüstle O; Boison D
Neurosci Lett; 2004 Nov; 370(2-3):160-5. PubMed ID: 15488315
[TBL] [Abstract][Full Text] [Related]
32. Molecular genetics of mucopolysaccharidosis type IIIA and IIIB: Diagnostic, clinical, and biological implications.
Yogalingam G; Hopwood JJ
Hum Mutat; 2001 Oct; 18(4):264-81. PubMed ID: 11668611
[TBL] [Abstract][Full Text] [Related]
33. Microglial precursors derived from mouse embryonic stem cells.
Napoli I; Kierdorf K; Neumann H
Glia; 2009 Nov; 57(15):1660-71. PubMed ID: 19455585
[TBL] [Abstract][Full Text] [Related]
34. Comparison of efficiency of terminal differentiation of oligodendrocytes from induced pluripotent stem cells versus embryonic stem cells in vitro.
Tokumoto Y; Ogawa S; Nagamune T; Miyake J
J Biosci Bioeng; 2010 Jun; 109(6):622-8. PubMed ID: 20471604
[TBL] [Abstract][Full Text] [Related]
35. Mouse embryonic stem cells are not susceptible to cytomegalovirus but acquire susceptibility during differentiation.
Matsukage S; Kosugi I; Kawasaski H; Miura K; Kitani H; Tsutsui Y
Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):115-25. PubMed ID: 16470616
[TBL] [Abstract][Full Text] [Related]
36. Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells.
Fukuhara Y; Li XK; Kitazawa Y; Inagaki M; Matsuoka K; Kosuga M; Kosaki R; Shimazaki T; Endo H; Umezawa A; Okano H; Takahashi T; Okuyama T
Mol Ther; 2006 Mar; 13(3):548-55. PubMed ID: 16316785
[TBL] [Abstract][Full Text] [Related]
37. In vitro differentiation of transplantable neural precursors from human embryonic stem cells.
Zhang SC; Wernig M; Duncan ID; Brüstle O; Thomson JA
Nat Biotechnol; 2001 Dec; 19(12):1129-33. PubMed ID: 11731781
[TBL] [Abstract][Full Text] [Related]
38. Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome.
Muschol N; Pohl S; Meyer A; Gal A; Ullrich K; Braulke T
Am J Med Genet A; 2011 Jul; 155A(7):1634-9. PubMed ID: 21671382
[TBL] [Abstract][Full Text] [Related]
39. [Experimental study on transplantation of embryonic stem cells in treating spinal cord injury].
Yang J; Li C; Zhai R
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):487-91. PubMed ID: 17578288
[TBL] [Abstract][Full Text] [Related]
40. Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA).
Hemsley KM; Hopwood JJ
Behav Brain Res; 2005 Mar; 158(2):191-9. PubMed ID: 15698885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
